In the high-stakes arena of federal healthcare fraud litigation, the role of the Actuary – Actuarial Expert Witness has become increasingly pivotal. A recent case, United States of America et al v. Supervalu Inc et al, provides a compelling example of how actuarial expertise can shape the outcome of complex disputes involving alleged violations of the False Claims Act.
Case Background and Parties
The case arose in the United States District Court for the Central District of Illinois, where relators (whistleblowers) brought suit against Supervalu Inc. and related pharmacy defendants. The relators alleged that the defendants submitted false or fraudulent claims to obtain federal funds from Government Healthcare Programs (GHP), in violation of the False Claims Act. The litigation centered on whether the defendants’ billing practices were consistent with regulatory requirements and industry standards, issues that demanded specialized actuarial analysis.


